Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients

American Journal of Kidney Diseases

Volumn 34, Issue 3, 1999, Pages 438-444

  Boaz, M ^a   Matas, Z ^a   Biro, A ^a   Katzir, Z ^a   Green, M ^a   Fainaru, M ^a   Smetana, S ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Cardiovascular disease; Hemostatic factors; Malondialdehyde; Oxidative stress

Indexed keywords

APOLIPOPROTEIN; FIBRINOGEN; LIPID; LIPOPROTEIN; MALONALDEHYDE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OXIDATIVE STRESS; PREVALENCE;

EID: 0032877305     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70070-3     Document Type: Article

References (34)

1. E Ritz M Koch Morbidity and mortality due to hypertension in patients with renal failure Am J Kidney Dis 21 suppl 2 1993 S113 S118
2. PS Parfrey Cardiac and cerebrovascular disease in chronic uremia Am J Kidney Dis 21 1993 77 80
3. MM Avram P Goldwasser DE Burrell A Antignani PA Fein N Mittman The uremic dyslipidemia: A cross-sectional and longitudinal study Am J Kidney Dis 20 1992 324 335
4. G Monzani F Bergesio R Ciuti A Rosati V Frizzi A Serruto D Vitali A Benucci PL Tosi S Bandini M Salvadori Lipoprotein abnormalities in chronic renal failure and dialysis patients Blood Purif 14 1996 262 272
5. AB Irish FR Green Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: Relationship with dyslipidaemia, inflammation, and factor VII genotype Nephrol Dial Transplant 13 1998 679 684
6. A Irish Cardiovascular disease, fibrinogen and the acute-phase response: Associations with lipids and blood pressure in patients with chronic renal disease Atherosclerosis 137 1998 133 139
7. AB Irish Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis Metabolism 46 1997 36 40
8. J Alwakeel AM Gader S Hurieb AK al-Momen A Mitwalli H Abu Laisha Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis Int Urol Nephrol 28 1996 255 261
9. BN Becker J Himmelfarb WL Henrich RM Hakim Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors J Am Soc Nephrol 8 1997 475 486
10. E Maggi R Bellazzi F Falaschi A Frattoni G Perani A Gazo M Nei D Romanini G Bellomo Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 45 1994 876 883
11. FJ Romero F Bosch-Morell MJ Romero EJ Jareno B Romero NM Marin J Roma Lipid peroxidation products and antioxidants in human disease Environ Health Perspect 106 suppl 5 1998 S1229 S1234
12. J Diaz E Serrano F Acosta LF Carbonell Reference intervals for four biochemistry analytes in plasma for evaluating oxidative stress and lipid peroxidation in human plasma Clin Chem 44 1998 2215 2217
13. RP Bird HH Draper Comparative studies on different methods of malondealdehyde determination Methods Enzymol 105 1984 299 305
14. WT Friedewald RI Levy DS Frederickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge Clin Chem 18 1972 499 502
15. JT Daurgirdas Second-generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error J Am Soc Nephrol 4 1993 1205 1213
16. Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA 269 1993 3015 3023
17. KR Shanmugasundaram K Srinivas P Sundaram D Sathyaraj R Muthu P Padma RU Maheswari V Veeraraghavan V Sharada B Amudha Lipid peroxidation, antioxidant defenses and red-cell membrane changes in relation to coronary risk index and symptomatic coronary heart disease J Cardiovasc Risk 2 1995 551 561
18. RM Hakim J Breyer N Ismail G Schulman Effects of dose of dialysis on morbidity and mortality Am J Kidney Dis 23 1994 661 669
19. E Ritz Why are lipids not predictive of cardiovascular death in the dialysis patient? Miner Electrolyte Metab 22 1996 9 12
20. O Panzetta L Cominacini U Garbin A Fratta-Pasini L Gammaro F Bianco A Davoli M Campagnola A DeSantis AM Pastorino Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: Effects of fish oil and vitamin E administration Clin Nephrol 44 1995 303 309
21. P Jackson CM Loughrey JH Lightbody PT McNamee IS Young Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure Clin Chem 41 1995 1135 1138
22. M Toborek T Wasik M Drodz M Klin K Magner-Wrobel E Kopieczna-Grzebieniak Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure Metabolism 41 1992 1229 1232
23. S Schmidtmann M Muller R von Baehr K Precht Changes of antioxidative homeostasis in patients on chronic hemodialysis Nephrol Dial Transplant 6 suppl 3 1991 S71 S74
24. S Lippa L Colacicco C Calla G Sagliaschi AG Angelitti Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and hemodialytic patients Mol Aspects Med 15 suppl 15 1994 S213 S219
25. E Peuchant MA Corbonneau L Dubourg MJ Thomas A Perromat C Vallot M Clerc Lipoperoxidation in plasma and red blood cells of patients undergoing hemodialysis. Vitamins A, E, and iron status Free Radic Biol Med 16 1994 339 346
26. V Schettler E Wieland R Verwiebe P Schuff-Werner F Scheler M Oellerich Plasma lipids are not oxidized during hemodialysis Nephron 67 1994 42 47
27. SE Roselaar NB Nazhat PG Winyard P Jones J Cunningham DR Blake Detection of oxidants in uremic plasma by electron spin resonance spectroscopy Kidney Int 48 1995 199 206
28. CM Loughrey IS Young JH Lightbody D McMaster PT McNamee ER Trimble Oxidative stress in hemodialysis Q J Med 87 1994 679 683
29. JL Paul ND Sall T Soni JL Poignet A Lindenbaum NK Man N Moatti D Raichvarg Lipid peroxidation abnormalities in hemodialyzed patients Nephron 64 1993 106 109
30. S Turi I Nemeth I Vargha B Matkovics E Dobos Erythrocyte defense mechanisms against oxygen radicals in hemodialyzed uraemic children Pediatr Nephrol 5 1991 179 183
31. MJ Richard J Arnaud C Jurkovitz T Hachache H Meftahi F Laporte M Foret A Favier D Cordonnier Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure Nephron 57 1991 10 15
32. L Triolo S Lippa A Oradei P DeSole R Mori Serum coenzyme Q10 in uremic patients on chronic hemodialysis Nephron 66 1994 153 156
33. G Stein S Sperschneider S Koppe Vitamin levels in chronic renal failure and need for supplementation Blood Purif 3 1985 52 62
34. MC Pastor C Sierra J Bonal J Teixido Serum and erythrocyte tocopherol in uremic patients: Effect of hemodialysis versus peritoneal dialysis Am J Nephrol 14 1994 246 248